Douglas R. Toal

814 total citations
16 papers, 578 citations indexed

About

Douglas R. Toal is a scholar working on Molecular Biology, Clinical Biochemistry and Spectroscopy. According to data from OpenAlex, Douglas R. Toal has authored 16 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Clinical Biochemistry and 4 papers in Spectroscopy. Recurrent topics in Douglas R. Toal's work include Metabolomics and Mass Spectrometry Studies (9 papers), Metabolism and Genetic Disorders (5 papers) and Analytical Chemistry and Chromatography (2 papers). Douglas R. Toal is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Metabolism and Genetic Disorders (5 papers) and Analytical Chemistry and Chromatography (2 papers). Douglas R. Toal collaborates with scholars based in United States and Iceland. Douglas R. Toal's co-authors include Anne M. Evans, Lisa A. Ford, Adam D. Kennedy, Zelalem Temesgen, Franklin R. Cockerill, Luke A. D. Miller, Sarah H. Elsea, Kirk L. Pappan, Sandra W. Clifton and Bruce A. Roe and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Douglas R. Toal

16 papers receiving 563 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Douglas R. Toal 296 125 105 70 61 16 578
Lin Zhan 261 0.9× 96 0.8× 50 0.5× 133 1.9× 25 0.4× 38 791
Brian O. Ingram 303 1.0× 60 0.5× 88 0.8× 50 0.7× 17 0.3× 21 654
Junxia Feng 280 0.9× 100 0.8× 38 0.4× 21 0.3× 27 0.4× 47 547
Brooke A. Napier 650 2.2× 173 1.4× 199 1.9× 160 2.3× 62 1.0× 23 1.2k
Qing Mei 125 0.4× 151 1.2× 47 0.4× 22 0.3× 45 0.7× 52 501
Julia Sanchez‐Garrido 361 1.2× 77 0.6× 72 0.7× 178 2.5× 14 0.2× 20 683
Thomas C. Sodeman 256 0.9× 134 1.1× 82 0.8× 10 0.1× 41 0.7× 42 745
Vijay Sivaraman 135 0.5× 161 1.3× 158 1.5× 37 0.5× 12 0.2× 28 518
Walther Honscha 167 0.6× 48 0.4× 38 0.4× 32 0.5× 38 0.6× 59 881
Giang T. Nguyen 228 0.8× 86 0.7× 63 0.6× 37 0.5× 9 0.1× 23 700

Countries citing papers authored by Douglas R. Toal

Since Specialization
Citations

This map shows the geographic impact of Douglas R. Toal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Toal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Toal more than expected).

Fields of papers citing papers by Douglas R. Toal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Toal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Toal. The network helps show where Douglas R. Toal may publish in the future.

Co-authorship network of co-authors of Douglas R. Toal

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Toal. A scholar is included among the top collaborators of Douglas R. Toal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Toal. Douglas R. Toal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ford, Lisa A., Matthew Mitchell, Jacob Wulff, et al.. (2022). Clinical metabolomics for inborn errors of metabolism. Advances in clinical chemistry. 107. 79–138. 7 indexed citations
2.
Kennedy, Adam D., Lisa A. Ford, Bryan M. Wittmann, et al.. (2021). Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives. PLoS ONE. 16(4). e0249797–e0249797. 19 indexed citations
3.
Goodman, Kelli D., Matthew Mitchell, Anne M. Evans, et al.. (2021). Assessment of the effects of repeated freeze thawing and extended bench top processing of plasma samples using untargeted metabolomics. Metabolomics. 17(3). 31–31. 13 indexed citations
4.
Ford, Lisa A., Adam D. Kennedy, Kelli D. Goodman, et al.. (2020). Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism. The Journal of Applied Laboratory Medicine. 5(2). 342–356. 116 indexed citations
5.
Freed, Tiffany A., Josef Coresh, Lesley A. Inker, et al.. (2019). Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS. Clinical Chemistry. 65(3). 406–418. 17 indexed citations
6.
Kennedy, Adam D., Bryan M. Wittmann, Anne M. Evans, et al.. (2018). Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing. Journal of Mass Spectrometry. 53(11). 1 indexed citations
7.
Zhang, Qibo, Lisa A. Ford, Anne M. Evans, & Douglas R. Toal. (2018). Identification of an Endogenous Organosulfur Metabolite by Interpretation of Mass Spectrometric Data. Organic Letters. 20(7). 2100–2103. 7 indexed citations
8.
Kennedy, Adam D., Bryan M. Wittmann, Anne M. Evans, et al.. (2018). Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing. Journal of Mass Spectrometry. 53(11). 1143–1154. 67 indexed citations
9.
Zhang, Qibo, Lisa A. Ford, Anne M. Evans, & Douglas R. Toal. (2017). Structure elucidation of metabolite x17299 by interpretation of mass spectrometric data. Metabolomics. 13(8). 92–92. 20 indexed citations
10.
Zhang, Qibo, et al.. (2016). LC–MS/MS method for quantitation of seven biomarkers in human plasma for the assessment of insulin resistance and impaired glucose tolerance. Journal of Chromatography B. 1038. 101–108. 12 indexed citations
11.
Walker, G. Terrance, et al.. (2015). Analytical Performance of Multiplexed Screening Test for 10 Antibiotic Resistance Genes from Perianal Swab Samples. Clinical Chemistry. 62(2). 353–359. 8 indexed citations
12.
Walker, G. Terrance, et al.. (2015). Rapid Molecular Screening for Gram-Negative Antimicrobial-Resistance Genes with Commercially Available Methods. Clinical Microbiology Newsletter. 37(21). 169–173. 1 indexed citations
13.
Temesgen, Zelalem, Douglas R. Toal, & Franklin R. Cockerill. (1997). Leclercia adecarboxylataInfections: Case Report and Review. Clinical Infectious Diseases. 25(1). 79–81. 67 indexed citations
14.
Mitchell, P. Shawn, Mark J. Espy, Thomas F. Smith, et al.. (1997). Laboratory diagnosis of central nervous system infections with herpes simplex virus by PCR performed with cerebrospinal fluid specimens. Journal of Clinical Microbiology. 35(11). 2873–2877. 84 indexed citations
15.
Toal, Douglas R., Sandra W. Clifton, Bruce A. Roe, & J S Downard. (1995). The esg locus of Myxococcus xanthus encodes the E1α and E1β subunits of a branched‐chain keto acid dehydrogenase. Molecular Microbiology. 16(2). 177–189. 63 indexed citations
16.
Toal, Douglas R., et al.. (1995). Branched‐chain fatty acids: the case for a novel form of cell‐cell signalling during Myxococcus xanthus development. Molecular Microbiology. 16(2). 171–175. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026